home / stock / alrn / alrn quote
Last: | $3.69 |
---|---|
Change Percent: | -0.8% |
Open: | $3.8 |
Close: | $3.69 |
High: | $3.86 |
Low: | $3.62 |
Volume: | 29,494 |
Last Trade Date Time: | 05/20/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.69 | $3.8 | $3.69 | $3.86 | $3.62 | 29,494 | 05-20-2024 |
$3.77 | $3.85 | $3.77 | $3.85 | $3.7 | 19,489 | 05-17-2024 |
$3.85 | $4 | $3.85 | $4 | $3.75 | 57,080 | 05-16-2024 |
$3.9 | $4 | $3.9 | $4 | $3.6501 | 20,862 | 05-15-2024 |
$3.9 | $3.87 | $3.9 | $3.99 | $3.74 | 48,242 | 05-14-2024 |
$3.88 | $3.81 | $3.88 | $3.93 | $3.71 | 17,117 | 05-13-2024 |
$3.82 | $3.79 | $3.82 | $3.99 | $3.6474 | 59,933 | 05-10-2024 |
$3.67 | $3.55 | $3.67 | $3.89 | $3.28 | 125,113 | 05-09-2024 |
$3.65 | $3.65 | $3.65 | $3.755 | $3.56 | 44,507 | 05-08-2024 |
$3.69 | $3.85 | $3.69 | $4.0498 | $3.61 | 241,733 | 05-07-2024 |
$3.95 | $3.8 | $3.95 | $4.01 | $3.8 | 87,752 | 05-06-2024 |
$3.76 | $3.79 | $3.76 | $4.17 | $3.75 | 142,725 | 05-03-2024 |
$3.82 | $4.29 | $3.82 | $4.3 | $3.76 | 149,308 | 05-02-2024 |
$4.16 | $4.31 | $4.16 | $4.5 | $3.7 | 483,852 | 05-01-2024 |
$4.55 | $4.99 | $4.55 | $5 | $4.47 | 319,110 | 04-30-2024 |
$4.92 | $4.97 | $4.92 | $5 | $4.8068 | 159,753 | 04-29-2024 |
$5 | $5.07 | $5 | $5.185 | $4.96 | 85,369 | 04-26-2024 |
$5 | $5.24 | $5 | $5.43 | $4.8358 | 80,550 | 04-25-2024 |
$4.93 | $4.88 | $4.93 | $4.93 | $4.65 | 102,247 | 04-24-2024 |
$4.75 | $4.74 | $4.75 | $4.99 | $4.512 | 67,714 | 04-23-2024 |
News, Short Squeeze, Breakout and More Instantly...
Aileron Therapeutics Inc. Company Name:
ALRN Stock Symbol:
NASDAQ Market:
Aileron Therapeutics Inc. Website:
Announced positive data from Cohort 1 of the Phase 1b clinical trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) patients with positive trends observed in seven of the eight biomarkers evaluated Topline results from Cohort 2 evaluating high-dose LTI-03 (5 mg BID) expected in ...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...
AUSTIN, Texas, May 06, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ:ALRN), a biopharmaceutical company advancing a no...